MSLN and renal carcinoma: Human mesothelin has been proposed to be a malignancy factor as it increased tumor cell proliferation and migration in vitro and tumor size in nude mice [5, 7], and siRNA specific for mesothelin suppressed tumor growth in a rat renal carcinoma model [9].